TNF Pharmaceuticals Inc TNFA
$5.20 $1.69 (48.15%) 1D
Last Updated: Sep 24, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
Pricing
Company
About Musaffa
Investors
Build with us
Is TNF Pharmaceuticals Inc Stock Halal?
Shariah Compliance Analysis of TNFA Stock
Germany Health Care Nano Cap No. As of September 2026, TNF Pharmaceuticals Inc (TNFA) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. TNF Pharmaceuticals Inc does not pass Musaffa's business and financial screening criteria.
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. Isomyosamine works by regulating the release of numerous pro-inflammatory cytokines. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the CBD market, which includes both Food and Drug Administration (FDA) approved drugs and CBD products not regulated as drugs.
TNFA Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, TNF Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
TNF Pharmaceuticals Inc (TNFA) Chart
Financial Metrics & Statements of TNF Pharmaceuticals Inc (TNFA)
FAQ's for TNF Pharmaceuticals Inc (TNFA)
- As of September 2026, TNF Pharmaceuticals Inc TNFA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes TNF Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in TNF Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of TNF Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of TNF Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of TNF Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for TNF Pharmaceuticals Inc (TNFA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
